Jamaican sprinter Veronica Campbell-Brown has been cleared to resume her career by the Court of Arbitration for Sport (CAS), her American-based lawyer Howard Jacobs said yesterday.

The twice Olympic 200 metres champion was suspended by her country’s national federation last year following a positive test for a banned diuretic.

“I can confirm that Veronica Campbell-Brown has been cleared by CAS,” Jacobs said.

“All of her past results have been reinstated and she is free to compete effective immediately.”

He said Campbell-Brown inten-ded to compete at the world indoor championships in Poland next month. The 31-year-old said she had suffered much in the last few months.

“However, my faith, family, friends and fans have stood by me as a source of encouragement,” she said. “The final court available to us as athletes have spoken and they have confirmed my innocence.

“I harbour too much self-respect and a similar respect for the purity of competition to resort to illegal means to success.”

Campbell-Brown tested positive for the banned diuretic hydro-chlorothiazide on May 4 at the Jamaica International Invitational World Challenge meet in Kingston.

She was provisionally suspended on June 18 by the Jamaican Athletics Administrative Association. The JAAA disciplinary panel announced in October a public reprimand for Campbell-Brown.

“Because the CAS hearing was completed on an extremely expedited basis, the full reasons for the award have not yet been issued, and may not be issued for a few months,” Jacobs said.

“However, it is clear the reason for the decision was a serious and fundamental breakdown in the manner in which Campbell-Brown’s urine sample was collected and handled in Jamaica on May 4, 2013.

“The integrity of the sample was not maintained and the results of any testing on that sample were therefore unreliable.”

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.